Ajaykumar Singh

Employment

Employment history is unavailable.

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (6)

• Sustained Complete Response to Brigatinib in a Young Patient With ALK‐Positive NSCLC Harboring I1171N Mutation Post‐Alectinib Resistance
  Case Reports in Oncological Medicine 2026 DOI: 10.1155/crom/7372418
  +Save
• Safety and Efficacy of Alectinib in the First Line for ALK-Mutated Lung Cancer: A Real-World Data from India
  South Asian Journal of Cancer 2025 DOI: 10.1055/s-0045-1806811
  +Save
• Clinical Profile and Outcomes of Carcinoma Penis Patients Receiving Systemic Therapy at an Indian tertiary care Center: A Retrospective Observational Study
  Clinical Genitourinary Cancer 2024 DOI: 10.1016/j.clgc.2024.02.004
  +Save
• Neoadjuvant Chemotherapy in Locally Advanced Sinonasal Teratocarcinosarcoma a Rare Malignancy: An Audit From an Academic Tertiary Care Centre in India
  Clinical Oncology 2024 DOI: 10.1016/j.clon.2024.03.017
  +Save
• The Role of Systemic Therapy in Patients with Advanced Non-small Cell Lung Cancer and a Poor Eastern Cooperative Oncology Group Performance Status
  Clinical Oncology 2023 DOI: 10.1016/j.clon.2023.12.001
  +Save
• Infections in Patients with Advanced-stage Epidermal Growth Factor Receptor-mutant Lung Cancer – a Post-hoc Analysis of a Randomised Trial
  Clinical Oncology 2023 DOI: 10.1016/j.clon.2023.09.016
  +Save